Alanosine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Alanosine
L-Alanosine.svg
Systematic (IUPAC) name
(S)-2-Amino-3-[hydroxy(nitroso)amino]propanoic acid
Clinical data
Legal status
?
Identifiers
CAS number 5854-93-3 YesY
ATC code None
PubChem CID 22128
ChemSpider 20787 YesY
UNII 2CNI71214Y YesY
ChEMBL CHEMBL452715 YesY
Chemical data
Formula C3H7N3O4 
Mol. mass 149.1 g/mol
 YesY (what is this?)  (verify)

Alanosine (also called SDX-102) is a substance that is being studied for the treatment of pancreatic cancer.[1] It is an antimetabolite. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of gemcitabine is no longer useful.

References[edit]

  1. ^ Yu J (2001). "Alanosine (UCSD).". Curr Opin Investig Drugs 2 (11): 1623–30. PMID 11763167.